SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-007929
Filing Date
2024-11-13
Accepted
2024-11-13 08:30:09
Documents
15
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm   iXBRL 8-K 30068
2 PRESS RELEASE xenetic_ex9901.htm EX-99.1 14900
3 GRAPHIC image_001.gif GRAPHIC 5333
  Complete submission text file 0001683168-24-007929.txt   230630

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xbio-20241113.xsd EX-101.SCH 3021
5 XBRL LABEL FILE xbio-20241113_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE xbio-20241113_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 3572
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 241451321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)